At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 20 enrolled
Drug / intervention
Gaymar Rapr-Round (external cooling blanket)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Temperature Control in Central Fever in the Neuro-ICU
In Brief
A Phase 4 clinical trial evaluating Gaymar Rapr-Round (external cooling blanket) for Fever and Brain Hemorrhage. Completed, enrolled 20 participants across 1 site.
Detailed Summary
There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket will reduce temperature in neurologically ill patients with central fever.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFever, Brain Hemorrhage
CountriesUnited States
CollaboratorsGaymar Industries, Inc.
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2008
Enrollment StartJan 2009
Primary CompletionJan 2011
TodayJul 2026
First PostedSep 12, 2008
Enrollment StartJan 1, 2009
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 17.8 years ago
Interventions
Gaymar Rapr-Round (external cooling blanket)device
Application of the device per its approved labeling